Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 4/20 | 0.34 |
| ▸ | TAS1R1 | Q7RTX1 | 4/20 | 0.34 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26133308 | 0.86 | TAS1R3 (0.40) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL16212910 | 0.83 | TAS1R3 (0.31) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL5548449 | 0.76 | TGFBR1 (0.38) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL1993819 | 0.76 | TGFBR1 (0.38) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL15903591 | 0.76 | TGFBR1 (0.38) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL16146113 | 0.75 | TAS1R3 (0.36) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL1988827 | 0.75 | TAS1R3 (0.36) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL28638694 | 0.73 | TAS1R3 (0.38) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL28652097 | 0.73 | TAS1R3 (0.38) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL17079800 | 0.73 | CYP2D6 (0.45) | TAS1R3TAS1R1TAS1R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9920319-B2 | 2′/3′/5′-(R/S)-serinyl functionalized oligonucleotides | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2018-03-20 | — | — | US | claimed |
| US-20170044527-A1 | Novel 2'/3'/5'-(R/S)-Serinyl Functionalized Oligonucleotides | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-02-16 | — | — | US | claimed |
| WO-2014178082-A1 | NOVEL 2'/3'/5'-(R/S)-SERINYL FUNCTIONALIZED OLIGONUCLEOTIDES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-11-06 | — | — | WO | claimed |
| US-9920319-B2 | 2′/3′/5′-(R/S)-serinyl functionalized oligonucleotides | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2018-03-20 | — | — | US | disclosed |
| US-20170044527-A1 | Novel 2'/3'/5'-(R/S)-Serinyl Functionalized Oligonucleotides | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-02-16 | — | — | US | disclosed |
| WO-2014178082-A1 | NOVEL 2'/3'/5'-(R/S)-SERINYL FUNCTIONALIZED OLIGONUCLEOTIDES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044527-A1 | Novel 2'/3'/5'-(R/S)-Serinyl Functionalized Oligonucleotides | RNGTT, NSUN2, ADAR | TAS1R3 3455/4885TAS1R1 3841/4885TAS1R2 3398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.